Literature DB >> 178609

Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.

C R Wohlenberg, M A Walz, A L Notkins.   

Abstract

Treatment of mice with phosphonoacetic acid markedly reduced the incidence of latent ganglionic infection with herpes simplex virus when administered within 24 h after viral inoculation, but had no effect on an already established ganglionic infection.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 178609      PMCID： PMC420791          DOI： 10.1128/iai.13.5.1519-1521.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

1.  Inhibition of herpes simplex virus replication by phosphonoacetic acid.

Authors:  L R Overby; E E Robishaw; J B Schleicher; A Rueter; N L Shipkowitz; J C Mao
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

Review 2.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

3.  Latent infection of the peripheral ANS with herpes simplex virus.

Authors:  R W Price; B J Katz; A L Notkins
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

Review 4.  Herpes simplex virus infection of nervous tissue in animals and man.

Authors:  J R Baringer
Journal:  Prog Med Virol       Date:  1975

5.  Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.

Authors:  D D Gerstein; C R Dawson; J O O
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

6.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

7.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

8.  Inhibition of DNA polymerase from herpes simplex virus-infected wi-38 cells by phosphonoacetic Acid.

Authors:  J C Mao; E E Robishaw; L R Overby
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

9.  Synthesis of herpes simplex virus, vaccinia virus, and adenovirus DNA in isolated HeLa cell nuclei. I. Effect of viral-specific antisera and phosphonoacetic acid.

Authors:  A Bolden; J Aucker; A Weissbach
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

10.  Suppression of herpes simplex virus infection by phosphonoacetic acid.

Authors:  N L Shipkowitz; R R Bower; R N Appell; C W Nordeen; L R Overby; W R Roderick; J B Schleicher; A M Von Esch
Journal:  Appl Microbiol       Date:  1973-09
  10 in total
  13 in total

1.  Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.

Authors:  R J Klein; A E Friedman-Kien; E Brady
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.

Authors:  R J Klein; A E Friedman-Kien; P B Yellin
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

3.  Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

4.  Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.

Authors:  R J Klein; E DeStefano; A E Friedman-Kien; E Brady
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

5.  Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

6.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

7.  Structure-activity studies on phosphonoacetate.

Authors:  J C Mao; E R Otis; A M von Esch; T R Herrin; J S Fairgrieve; N L Shipkowitz; R G Duff
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

8.  Effects of topical applications of phosphonoacetate on colonization of mouse trigeminal ganglia with herpes simplex virus type 1.

Authors:  R J Klein; A E Friedman-Kien; L Kaley; E Brady
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

9.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.

Authors:  B Svennerholm; A Vahlne; E Lycke
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.